Thus, we postulate that high IL-6 expression is closely associated with low NKp30 expression in NK cells, facilitating NK cell dysfunction and poor prognosis in NSCLC patients in vivo. This evidence concerns the gene NCR3 and non-small cell lung carcinoma.